Get access

Long-term effects of weight-reducing drugs in hypertensive patients

  • Protocol
  • Intervention



This is the protocol for a review and there is no abstract. The objectives are as follows:

Primary objectives:

To assess the long-term effects of pharmacologically induced reduction in body weight in hypertensive patients with orlistat, sibutramine or rimonabant on:
- all cause mortality
- cardiovascular morbidity
- adverse events

Secondary objectives:

- changes in systolic and/or diastolic blood pressure
- body weight reduction

Get access to the full text of this article